Skip to main content

Mather Group, LLC.

SEC CIK
0001527641
Latest filing
Jul 27, 2026

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Mather Group, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings

Shares (Q2 2026)
1,030
Value
$3.78K
% of portfolio
<0.1%
Quarters held
3
Since Q3 2025
Holdings of RXRX by Mather Group, LLC., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,030$3.78K<0.1%−1,250−54.8%ReducedHolders
Q1 20262,280$7.00K<0.1%+2,280NewHolders
Q4 20250$00.0%−1,030−100.0%Sold outHolders
Q3 20251,030$5.03K<0.1%+1,030NewHolders